Beijing, China

Hong Ma

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Chinese Academy of Sciences, Fosse Bio-Engineering Development, Ltd., Peking University. Active years: 2006-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hong Ma. Retrieved from https://idiyas.com/inventor/hong-ma-rdqbfq8n

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 50.0

Average Co-Inventor Count = 4.8

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2006-2013

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Inventor Hong Ma

Introduction

Hong Ma is a prominent inventor based in Beijing, China. He has made significant contributions to the field of biotechnology, particularly in enhancing the tolerance of aquatic species to low oxygen levels and developing innovative insulin formulations. With a total of 2 patents, his work has the potential to impact both aquaculture and diabetes treatment.

Latest Patents

One of Hong Ma's latest patents is a recombinant gene that enhances the ability of fish to tolerate low dissolved oxygen stress. This invention utilizes the carp β-actin gene promoter and the hemoglobin gene to construct a recombinant hemoglobin gene. The research focuses on zebrafish as a model organism, where the recombinant gene is microinjected into zygotes. The results showed a survival rate of 92% for transgenic fish under low oxygen conditions, compared to 65% for the control group. This genetically improved breeding technique could be applied to economically important species like blunt snout bream and common carp, enhancing their hypoxia tolerance.

Another significant patent by Hong Ma is a method for preparing an orally administrated insulin formulation. This method involves dissolving insulin in an acidic aqueous buffer and combining it with a liquid surfactant to create a stable oil formulation. The formulation is designed to resist gastrointestinal degradation and facilitate easy absorption, providing a hypoglycemic effect. This innovative approach offers a simple and cost-effective solution for insulin delivery.

Career Highlights

Hong Ma has worked with esteemed organizations such as the Chinese Academy of Sciences and Fosse Bio-Engineering Development, Ltd. His experience in these institutions has contributed to his expertise in biotechnology and innovation.

Collaborations

Throughout his career, Hong Ma has collaborated with notable colleagues, including Changxue Zheng and Housheng Zhong. These partnerships have fostered a collaborative environment that enhances research and development in his field.

Conclusion

Hong Ma's contributions to biotechnology through his innovative patents demonstrate his commitment to advancing scientific knowledge and practical applications. His work not only addresses critical challenges in aquaculture but also offers new solutions for diabetes management.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…